ABSTRACT Three different human tumor lines in culture, a rhabdomyosarcoma, a bronchogenic carcinoma and a metastatic melanoma, release proteins (transforming growth factors, TGFs) into the medium that confer the transformed phenotype on untransformed fibroblasts. These proteins are acid and heat-stable; produce profound morphologic changes in rat and human fibroblasts; and enable normal anchorage-dependent cells to grow in agar. Removal of the transforming protein results in a reversion of cell phenotype. The major activity interacts with epidermal growth factor (EGF) cell membrane receptors. The peptides from these tumor cells are similar in their action to the sarcoma growth factor (SGF) released by murine sarcoma virus-transformed rodent cells. The most anchorageindependent tumor cells released the most TGFs. EGF-related TGFs were not detectable in fluids from cultures of cells with high numbers of free EGF membrane receptors (normal human fibroblasts and human carcinomas). Mouse sarcoma virus (MSV)-and rat sarcoma virus-transformed cells release a potent growth-stimulating peptide that interacts with epidermal growth factor (EGF) receptors (1, 2). This ability has been utilized to purify sarcoma growth factor (SGF) produced by MSV-transformed cells (3). It has been noted that certain human sarcoma and carcinoma cells (4) and most melanomas (5) lack EGF receptors and, therefore, may produce endogenous factors related to EGF and SGF. To test this possibility, serum-free media were collected from four human tumors and normal human fibroblasts and partially purified. Cells that lack EGF receptors released a potent growth-stimulating activity that enabled normal fibroblasts and epithelial cells to proliferate in soft agar. Supernates from normal human fibroblasts possessed <2% as much activity.
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A human epidermoid carcinoma cell (A431) with an exceptionally high number of EGF receptors (4, 6, (8) . Neither has detectable EGF receptors (4) . The human epidermoid carcinoma A431, from a primary vulvar carcinoma in an 85-year-old woman, has an exceptionally high number of EGF receptors (4, 6) . The human metastatic melanoma line A2058, from a brain metastasis in a 43-year-old man, has nerve growth factor (NGF) receptors (5) and free NGF on its cell surface (9) . TE85 is a human osteosarcoma line from J. Rhim (National Institutes of Health). The human embryonic lung cell HEL 299 is from the American Type Culture Collection, Rockville, MD; the adult skin strain HsF is from a normal female; and 49F is a clone of fibroblastic cells (10) from the normal rat kidney line NRK (11) .
Growth Factors. Serum-free conditioned media from the human tissue culture cells were the source of growth factors. In each case, cells were grown to confluency in DME medium with calf serum and washed twice with serum-free Waymouth's medium (GIBCO, MD 705/1), once for 8 hr and once for 16 hr, to eliminate serum proteins. The washes were discarded and subsequent 48-hr collections were taken as "conditioned medium". The medium was centrifuged at 100,000 X g for 45 min and concentrated 25-fold using a hollow fiber concentrator (Amicon, Lexington, MA; DC2). The concentrate was dialyzed against four changes (10 vol each) of 1% HOAc, lyophilized, and extracted with 1 M HOAc. This extract was centrifuged (100,000 X g for 120 min), and the supernate was subjected to Bio-Gel P-100 chromatography with a column equilibrated and eluted with 1 M HOAc (1).
Chromatography on CM-Cellulose. The lyophilized fractions from the biologically active region from the P-100 column were pooled, reconstituted in 5 ml of 1 M HOAc, and dialyzed against 5 mM NH4OAc (pH 4.5) overnight at 4VC. The sample was centrifuged at 175,000 X g for 30 min at 220C and applied to a 1.5-X 3-cm column of CM-cellulose (CM-52, Whatman). Elution was achieved with a linear gradient pumped from a two-chamber, constant-level device containing 200 tiated by adding 0.2 ml of binding buffer containing 2 ng of 125I-EGF per ml with or without the potential inhibitor. The mixtures were incubated with the monolayers at 22°C for 1 hr, the 125I-EGF-containing buffer was removed, the cell sheet was washed four times with 1-ml portions of binding buffer, and the quantity of 125I-EGF specifically bound was determined.
Soft Agar Growth Assay. The lyophilized fractions were redissolved in binding buffer at five times the final concentration used in the assay and centrifuged to clarity. Samples containing 3 X 10P cells per ml were suspended in 0.3% agar (Difco, Agar Noble) in DME medium with 10% calf serum; 0.7 ml was pipetted onto a 0.7-ml base layer of 0.5% agar in 35-mm petri dishes (Falcon). Plates were incubated at 37'C for 2 weeks in a humidified 5% C02/95% air atmosphere without further feeding. The assay was read unfixed and unstained at 5 days and at 10-14 days.
Cellular DNA Synthesis Assay. Serum-deprived, subcon- (10) were seeded at 5 X 104 cells per 16-mm well (Linbro no. 76-033-05) in DME medium with 10% calf serum. After 4 hr, the medium was removed; the cells were washed with fresh serum-free medium and incubated with 1 ml per well of Waymouth's medium containing 0.1% calf serum. Seven days later, 0.1 ml of bindingbuffer containing the sample to be tested was added. After 16 hr, the cells were exposed for 5 hr to 4.0 mCi (1 Ci = 3.7 X 1010 becquerels) of [3H]thymidine (New England Nuclear; NET-027), washed twice with 1 ml of DME medium containing 100 tig of unlabeled thymidine per ml, incubated for 30 min, washed three times, and disrupted with 0.5% sodium dodecyl sulfate/i mM EDTA. DNA was precipitated by adding the lysate to 3 vol of cold 10% CC13COOH and was removed by filtration (Millipore;
HA, 0.45 aim); the filters were dried and added to counting vials with 5 ml of toluene/Liquifluor (New England Nuclear, NEF 903), and the radioactivity was measured in a liquid scintillation counter (Beckman, LS-250).
RESULTS
The three tumor cells tested for production of factors analogous to SGF were chosen for study because they had no apparent EGF receptors and readily form colonies in soft agar. Norn. al embryonal lung fibroblasts, which are unable to grow in soft agar, and A431 cells, which have a very high number of EGF receptors and grow poorly in soft agar, were used as controls. The five cultures were compared for their ability to form colonies in soft agar. The cells were grown in monolayer cultures, harvested, and seeded at varying densities into medium with 0.3% agar. Colonies were scored at 5 and 10 days. Colonies with more than 10 cells were counted as positive. The results shown in Fig. 1 that a critical concentration of diffusible factors from these cells is required for anchorage-independent growth.
Cells The identical procedure was used to test for growth-stimulating factors and EGF-competing peptides from the supernates of four other human cell cultures. Fig. 3 shows that the two highly transformed tumor cell lines, 9812 and A2058, release a growth-stimulating and EGF-competing material with an apparent molecular weight of 20,000-23,000 (Fig. 3 B and C) . A2058 cells release a second factor with an apparent molecular weight of 6000-7000. Fig. 3A shows that the supernate from normal human fibroblast cells did not release a detectable growth-stimulating activity and had no significant EGFcompeting activity. A431 cells showed a smaller peak of growth-stimulating activity with an apparent molecular weight of 21,000; no EGF-competing activity was found. Fig. 4A shows a dose-response curve measuring growth in soft agar as a function of protein concentration. The pooled, peak fractions from A673 cells are compared with those from normal human fibroblasts. There was a 50-to 100-fold difference in growth-stimulating activity in soft agar.
The relative sensitivities of three different assays for growth-stimulating activity are compared in Fig. 4B . The data is presented as the percentage of the maximal response. Induction of DNA synthesis as tested with serum-depleted rat fibroblast monolayer cultures was slightly more sensitive than the soft agar growth assay; EGF-competing ability was the least sensitive. The latter two assays were used in further studies because they have greater specificity. Each of the TGF activities was destroyed by trypsin or dithiothreitol but was stable at 100°C for 2 min and to repeated lyophilization from 1 M HOAc. Table 1 shows that the growth-stimulatory factor(s) released by the human tumor cells induce anchorage-independent growth of normal human fibroblasts. Two cell strains were tested; passage 8 of HEL 299 and passage 14 of HsF. A673 cells were tested at concentrations of 10,ug/ml and 1 ,g/ml. Cells were seeded (1 X 104 per plate) and 1000 single cells were followed for 2 weeks. Those that grew to colonies containing 10 cells were scored as positive. The percentages of HEL 299 and HsF single cells that gave rise to colonies were 4.2% and 3.1%, respectively, using 10,ug of P-100-purified TGF per ml. In contrast, 23 .6% of the rat fibroblast cells showed a pronounced response, even at a concentration of 1 ,ug/ml. TGF also induced soft agar growth of a mouse epithelial cell line, MMC-1 (14) (data not shown).
In order to test whether human tumor cell lines could also respond to TGFs, cells such as A431, which untreated could not form colonies in agar unless inoculated at high density, were used. Carcinoma cell growth in agar also depends on "conditioning" factors, such as TGFs, which partially replace the requirement for high-cell density. The results were more striking when the human osteosarcoma line TE85, which can be further transformed by MSV and certain chemical carcinogens (15), was used as an indicator cell. These results demonstrate that normal and tumor cells respond to TGFs in the same manner as rat fibroblasts. The results, then, are not dependent on an unusual property of a particular indicator cell, The active fractions from Bio-Gel P-100 columns of A673 and A431 cells were pooled, concentrated, and applied to CM-cellulose columns. Two peaks of agar growth-stimulating activity were obtained from A673 cells; only the major activity was associated with the peak of EGF-competing activity. Dose-response curves from each peak show an activity detectable when concentrations of 10 to 20 ng/ml are added to soft agar. The comparable fraction from supernates of cultures of the normal human fibroblast showed no activity. Fractions derived from A431 cells showed (Fig. 5) only the less active, earlier eluting peak that is not associated with EGF-competing activity. We conclude that A431 cells that grow poorly in agar and have a high level of EGF receptors produce a factor capable of stimulating anchorage-independent growth of cells through a mechanism independent of the EGF receptor system. The highly transformed A673 cells, however, make at least two different factors. One interacts with the EGF receptor system and accounts for >90% of the total activity in the fraction. The other is independent of the EGF receptor system and may be analogous to the factor produced by the A431 cells. Proc. Nati. Acad. Sci. USA 77 (1980) DISCUSSION The results demonstrate that human tumor cells produce a growth factor(s) capable of inducing transformation in normal indicator cells. It has many properties in common with the factor from mouse and rat sarcoma virus-transformed cells. The major activity, although considerably larger than SGF, is closely associated with EGF-competing activity. We have found that a chemically transformed mouse 3T3 cell line produces growth-stimulating factor(s) active in the soft agar growth assay (unpublished data). Production of these factors then, is not restricted to RNA tumor virus-transformed cells, sarcoma cells, or rodent cells, but, rather, may be a more general expression of the transformed phenotype. In assays comparing growth stimulation of mouse, rat, and human fibroblasts in monolayer cultures, there is no evidence for species specificity of the factors produced by human cells. Conclusions as to whether the carcinoma, sarcoma, and melanoma cells are producing an identical factor(s) await further chemical purification. The present experiments show that anchorage-independent growth of tumor and normal cells is stimulated by these growth factors. Their production by transformed cells and the responses of their normal counterparts raise the possibility that cells "auto-stimulate" their growth by releasing factors that rebind at the cell surface (4 (17) .
If release of the factor and rebinding to EGF receptors is essential for growth stimulation, tumor cell growth could be interrupted by exogenous agents, perhaps analogues that interact with the receptors but do not confer the ability to proliferate under anchorage-independent conditions (18) . Anchorage-independent growth is a cell culture property closely associated with the transformed state in vivo (19, 20) . These peptides, then, are potent proximal effectors of cell transformation. Their continued production appears to play a role in maintaining the transformed phenotype. This can be directly demonstrated in temperature-sensitive mutant transformants of rodent cells (2, 17) but has not yet been shown for factors produced by human tumor cells. The approach described here offers a sensitive assay for growth-stimulatory factors associated with maintaining the transformed state. Purification of such factors may lead to the development of specific immunologic assays for their production by tumor cells and their presence in body fluids. The factors may be analogous to peptide growth factors expressed early in normal embryonic development (2) . This is supported by experiments by Nexo et al. (21) . In the mouse embryo (days [11] [12] [13] [14] [15] [16] [17] [18] , there is 5-10 times more EGF-like material than mouse EGF. Why the factors produced by transformed cells are so potent in stimulating anchorage-independent growth whereas EGF is not effective is unclear, but that fact suggests the possibility that there may be more "transforming" variants of the normally expressed growth factors produced in adult life. We suggest that these factors, like SGFs, are EGF-related peptides [as insulin and somatomedins are related (22) ] and appear to have evolved from common ancestral proteins (23) . Further purification of these growth factors from human tumor cells is needed to define their relationship to other biologically active peptides that cells produce.
